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abstract: For decades it was believed that a non-renewable pool of oocyte-containing follicles is established in female mammals at
birth. This cornerstone of reproductive biology was challenged 5 years ago by a study reporting on the presence of mitotically-active
germ cells in juvenile and adult mouse ovaries. Additional ﬁndings presented in this study and others that followed further suggested that
mammals retain the capacity to generate oocytes during adulthood; however, isolation of oocyte-producing germline stem cells (GSC) as
unequivocal proof of their existence remained elusive. This piece of information now appears to have been provided by Ji Wu and colleagues.
In addition to showing that proliferative germ cells resembling male spermatogonial stem cells can be puriﬁed from neonatal or adult mouse
ovaries and maintained in vitro for months, transplantation studies demonstrated that these cells generate oocytes in ovaries of chemother-
apy-sterilized recipients that fertilize and produce viable offspring. Although these ﬁndings do not establish that oogenesis occurs in adult
females under physiological conditions, they strongly support the existence of GSC in adult mouse ovaries. If equivalent cells can be
found in human ovaries, stem cell-based rejuvenation of the oocyte reserve in ovaries on the verge of failure may one day be realized.
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Introduction
One of the most exciting, and controversial, developments in female
reproductive biology over the past several years relates to an increasing
bodyofevidencethattheovarianfolliclepoolmaybereplenishedduring
adult life by a rare population of putative germline stem cells (GSC)
(Johnson et al., 2004; reviewed by Tilly et al., 2009). Although the exist-
ence ofGSCandthe occurrenceofoogenesisintheovariesofadultﬂies
(reviewed by Kirilly and Xie, 2007) and non-mammalian vertebrates
(PearlandSchoppe,1921;Draperetal.,2007)arewell-acceptedﬁndings,
claimsthattheovariesofmammalianfemalesretainacomparable popu-
lationofoocyte-producingstemcellsstandinstarkcontrasttomorethan
ﬁvedecadesoftraditionalthinking.Thedogmathatfemalemammalsare
bornwithalloftheoocytestheywilleverpossesshasitsfoundationsina
paper from Sir Solomon Zuckerman published in 1951 (Zuckerman,
1951), which overviews his reasons for arriving at this conclusion.
Simplyput,Zuckermanfailedtoﬁndanyexperimentalevidenceavailable
at that time that he felt was inconsistent with an earlier hypothesis
(Waldeyer, 1870) that germ cell production in female mammals ceases
prior tobirth (reviewed byZuckerman,1971).This articleand itsprinci-
pal conclusion profoundly affected the subsequent interpretation of
experimental and clinical observations relating to ovarian development,
function and failure for the next 50 years. Indeed, the entire premise of
why age-related ovarian failure and menopause occur has its roots in
the belief that mammalian females lack the ability to replenish their
oocytereserve,resultinginaprogressiveandirreversibledeclineinfollicle
numbersuntilthepoolisexhaustedatsomepointduringadultlife(Faddy
etal.,1992).Theconsequencesofthisaresigniﬁcanttoconsider,notonly
inthecontextofalossoffertilepotentialbutalsointhebroaderpictureof
thediversespectrumofage-relatedhealthproblemsthatemergeinpost-
menopausal women linked to failure of their ovaries (Prior, 1998;
Buckler, 2005). In turn, if it were possible to repopulate adult ovaries
with new oocytes and follicles, the female biological clock would no
longer be an unreachable target for clinical intervention.
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in aging females
The existence of a close relationship between ovarian function
and general health in females has been known for many years.
In humans, ovarian failure at menopause has been causally associated
with increased risks for the development of a long list of signiﬁcant
health complications, including osteoporosis, cardiovascular disease,
recurrent depression and cognitive dysfunction (Prior, 1998; Buckler,
2005; Frey et al., 2008). In addition, other less physically debilitating
problems, such as heat intolerance and hot ﬂushes, also negatively
impact on the quality of life in peri- and post-menopausal women
(Santoro, 2008). That ovarian failure is directly tied to these events
is borne out by follow-up studies of young girls and reproductive
age women treated for cancer with cytotoxic drugs or radiation.
Many of these treatments, whereas effective at killing cancer cells,
also inadvertently accelerate depletion of immature ovarian follicles
(reviewed by Tilly, 2001; see also Oktem and Oktay, 2007). In turn,
a premature onset of infertility and menopause is frequently observed
in these patients, along with many of the same health complications
that occur in aging women after natural menopause (Molina et al.,
2005; Oktay and So ¨nmezer, 2008; Schover, 2008; Wo and
Viswanathan, 2009).
Evidence from laboratory animal studies agrees with these clinical
data. Like that seen in humans (Richardson et al., 1987), female
mice exhaust their follicle reserves long before death due to advanced
age (Gosden et al., 1983). Subsequent to this ovarian failure, aged
female mice exhibit an increased incidence of many health problems
commonly associated with post-menopausal life in women, including
obesity, declining muscle and bone strength and neurological defects
(Perez et al., 2007). Thus, mice have been a model of choice to
examine the consequences of age-related follicular depletion on
overall health and even longevity. For example, aging female mice
exhibit striking increases in life expectancy after receiving transplants
of young adult ovary tissue (Cargill et al., 2003). In other studies, dis-
ruption of the gene encoding Bax, which is involved in promoting
age-associated oocyte loss and follicle atresia (Perez et al., 1999),
extends ovarian lifespan and reduces the incidence of bone and
muscle loss, excess fat deposition, alopecia, cataracts, deafness,
increased anxiety and selective attention deﬁcit with age (Perez
et al., 2007). Importantly, aged Bax-null females do not exhibit an
increased incidence of cancer in any tissue, including the mammary
glands and uterus which are highly responsive to steroids produced
by the ovaries (Knudson et al., 2001; Perez et al., 2007). These ﬁndings
collectively indicate that experimentally induced maintenance of
ovarian function in aging females can be used to achieve signiﬁcant
improvements in health, well-being and life expectancy.
Evidence for the existence of
GSC in mammalian females
In March of 2004, a study was published reporting the presence of
germline cells, as deduced by morphological criteria and expression
of an evolutionarily conserved germline-speciﬁc marker (mouse vasa
homolog or MVH), in or proximal to the surface epithelium of juvenile
and adult mouse ovaries that exhibited evidence of mitotic activity (i.e.
incorporation of bromodeoxyuridine or BrdU, and chromatin changes
consistent with cells in prometaphase and metaphase). The existence
of these cells, designated as presumptive GSC, along with other sup-
porting data were offered as evidence that the longstanding dogma
that mammalian females lose the capacity to produce new oocytes
at birth was incorrect (Johnson et al., 2004). Numerous commentaries
followed with various assessments of both the data presented and the
validity of this claim (reviewed by Tilly et al., 2009), which by most
accounts were a shock to the ﬁeld (Lemonick, 2004; Powell, 2007).
A debate that started over a century ago (reviewed by Everett,
1945) and was long-since believed to be settled (Zuckerman, 1951),
was now reopened for discussion. Although this debate has since
been perceived as representing two clearly opposing viewpoints
with no common ground (reviewed by Powell, 2007), the existence
of GSC in mammalian ovaries is not necessarily inconsistent with
the idea that females are born with all of the oocytes they will ever
have. Indeed there is the possibility that both views can co-exist,
with the formation of a ﬁxed population of oocytes at birth that is nor-
mally not subject to renewal and the existence of GSC in adult ovaries
that can only be activated under speciﬁc circumstances. Since it is
impossible to prove beyond any doubt the absence of any given cell
in a tissue, the debate cannot be fully resolved until the presence
and function of GSC within adult ovaries can be unequivocally
demonstrated.
In this regard, the initial report from Johnson et al. (2004) indicated
that the cells they identiﬁed as putative GSC in juvenile and adult
mouse ovaries were extremely rare, as one might expect of a stem
cell population in vivo. Follow-up studies also suggested a possible
extra-ovarian origin of female GSC in adult mice (Johnson et al.,
2005a). This conclusion was based on observations of regulated germ-
line marker expression in bone marrow- and peripheral blood-derived
cells, as well as the formation of what appeared, at least by accepted
morphological and gene expression characteristics, to be donor-
derived immature oocytes in ovaries of chemotherapy-treated or
genetically-sterile female recipients transplanted with bone marrow
or blood cells from transgenic females with germline-speciﬁc
expression of green ﬂuorescent protein (GFP) (Johnson et al.,
2005a). However, the interpretation and physiological signiﬁcance of
these ﬁndings, and their bearing on the validity of the dogma that
the oocyte pool is ﬁxed at birth, were quickly disputed (Telfer et al.,
2005; see also reply by Johnson et al., 2005b). Subsequent investi-
gations demonstrated that putative bone marrow- and blood-derived
germ cells fail to generate developmentally competent oocytes after
induced (Eggan et al., 2006) or spontaneous (Lee et al., 2007a) ovu-
lations, although such outcomes do not contradict ﬁndings of donor-
derived immature oocytes being formed in recipient ovaries following
parabiosis (Tilly et al., 2009) or transplantation of marrow- or blood-
derived cells (Johnson et al., 2005a; Lee et al., 2007a). It is also note-
worthy here that bone marrow transplants reportedly sustain or
restore the function of ovaries that are failing due to chemotherapy
exposure (Lee et al., 2007a; Fu et al., 2008) or advancing age
(Selesniemi et al., 2009), with all offspring derived from the host
females.
In any case, the successful isolation and characterization of putative
female GSC remained elusive, despite experimental results from a
handful of laboratories offered as additional evidence against the
idea that mammalian females lose the capacity to produce new
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presented in support of oocyte renewal during adulthood have ranged
from morphometry-based results reporting the mathematical improb-
ability of a non-renewable oocyte pool being established at birth in
rodents (Johnson et al., 2004; Kerr et al., 2006; see also Allen,
1923)—consistent with historical assessments of oocyte dynamics in
rhesus monkeys that reached the same conclusion (Vermande-Van
Eck, 1956)—to outcomes of studies showing increased oocyte
numbers in adult ovaries by either pharmacologic enhancement of
basal oogenesis or oocyte regeneration after a pathological insult
that initially depletes the resting follicle pool (Johnson et al., 2005a;
Borovskaya et al., 2006). Genetic approaches have also been
employed, leading to identiﬁcation of the Cables1 cell cycle-regulatory
gene as a key regulator of post-natal oogenesis in adult mice (Lee
et al., 2007b). Other studies identiﬁed the Caspase-6 gene as a poten-
tial modulator of post-natal oogenesis (Skaznik-Wikiel et al., 2007).
However, the interpretations and conclusions of these studies were
based on the presumed existence of a cell type that had not yet
been isolated, or at least demonstrated to have complete germline
potential. Given this, and the fact that the case against oocyte regen-
eration during adulthood was represented by a body of work spanning
more than 50 years (reviewed by Gosden et al., 2009), additional evi-
dence supporting the existence of pre-meiotic germ cells capable of
producing new oocytes in adult ovary tissue was deemed necessary
by many scientists to understand and accept these claims (Powell,
2007; reviewed by Tilly et al., 2009).
Puriﬁcation of mammalian
female GSC
A key ﬁnding supporting claims that adult mouse ovaries retain the
capacity for oogenesis came in April of 2009, with a report that the
equivalent of male spermatogonial stem cells had been successfully
isolated from neonatal and adult mouse ovaries (Zou et al., 2009).
These cells, termed female germline stem cells (FGSC), were initially
identiﬁed using the same criteria employed by Johnson et al.
(2004)—namely, expression of MVH and BrdU incorporation. Immu-
nomagnetic beads coupled to MVH antibody were then utilized to
purify cells positive for MVH expression from enzymatically-dispersed
neonatal or adult mouse ovaries, and these cells were subsequently
placed in culture on mitotically-inactivated mouse embryonic ﬁbro-
blasts. The medium used to achieve long-term and stable in-vitro
propagation of the presumptive FGSC was similar in composition to
that used for the in-vitro support of male GSC (often referred to as
spermatogonial stem cells). As of the online publication date of this
study, neonatal and adult ovary-derived FGSC had been successfully
maintained and passaged for more than 20 and 10 months, respect-
ively. Further, it was shown that cryopreserved and thawed FGSC
could be re-established in culture (Zou et al., 2009).
Although these observations support the claim that
mitotically-active germline cells were successfully isolated from post-
natal mouse ovaries, the protocol employed by Zou et al. (2009) to
accomplish this has already been viewed by some with skepticism
since MVH is classically considered to be an intracellular protein in
germ cells (Fujiwara et al., 1994; Toyooka et al., 2000). As such, the
use of MVH antibodies coupled to magnetic beads to viably isolate
these cells seems at odds with its spatial expression pattern.
However, in reading the supplementary information provided by
Zou et al. (2009), their computer-based bioinformatics analysis of
MVH protein revealed the presence of two consensus membrane-
spanning helix domains that had not been reported previously.
Our assessment of MVH using the TMpred program employed
by Zou and colleagues (http://www.ch.embnet.org/software/
TMPRED_form.html) conﬁrmed the presence of these two consensus
transmembrane domain sequences. Further, our orientation analysis is
fully compatible with the predicted extracellular C-terminal sequence
of MVH being recognized on the outside of germ cells by the antibody
used by Zou and colleagues to isolate FGSC (unpublished obser-
vations). It is important to emphasize, however, that these types of
programs are only predictive in nature, and thus the possibility that
MVH can exist in germ cells as a transmembrane protein remains to
be experimentally proven.
Irrespective, perhaps the most striking and signiﬁcant aspect of this
study from Zou et al. (2009) was their observation that either neonatal
or adult ovary-derived FGSC could reconstitute ovarian function in
adult female mice rendered sterile by treatment with busulphan and
cyclophosphamide. Using a retrovirus to convey expression of GFP
in FGSC prior to transplantation, additional experiments showed
that GFP-positive oocytes contained within follicles at all maturational
stages were formed in the ovaries of chemo-ablated wild-type female
mice transplanted with FGSC. Furthermore, mating trials performed
with the transplanted females yielded offspring containing the GFP
transgene in their genomic DNA, which was successfully carried
over into a second generation of offspring. Parallel evaluations of
chemotherapy-treated females not receiving the FGSC transplants
revealed complete ovarian failure and infertility (Zou et al., 2009).
Given that similar approaches have been employed to characterize
GSC in males, the data presented in this new study offer a compelling
argument for the existence of GSC in adult mammalian females which,
at least under the experimental conditions described by Zou et al.
(2009), are fully capable of generating oocytes that can fertilize and
yield viable offspring.
Implications and limitations
of these new results
As exciting as these new ﬁndings are, some caution needs to be exer-
cised in evaluating the immediate signiﬁcance of the work to our
understanding of the in-vivo biology of ovarian function, as well as
the ultimate relevance of this work to reproductive health in
women. The successful puriﬁcation and characterization of what
appear to be bona ﬁde female GSC from neonatal and adult ovary
tissue in mice, although important, does not immediately equate to
proof that these cells serve a contributory role in determining the
size of the post-natal follicle pool or the timing of ovarian failure
under normal physiological conditions. Indeed, it may be that the
full germline potential of these cells only arises as a consequence of
their long-term culture in vitro and that their oogenic activity is nor-
mally suppressed in vivo. Additional work will be needed to assess
this, although the study of Zou et al. (2009) provides a critical spring-
board on which to launch such follow-up investigations. Furthermore,
all of the work discussed has focused on the formation of new
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interact with somatic (granulosa) cells. The location and characteriz-
ation of a putative granulosa stem cell niche is still to be conﬁrmed,
and it may be that the number or activity of these cells restricts the
function of GSC in vivo. Whatever the case, even if activity of these
GSC in vivo is shown and it is accepted that these cells function to
sustain the adult follicle pool by partially offsetting the high rate of fol-
licle loss through atresia, these GSC still fail to maintain ovarian func-
tion with advancing age. Indeed, their existence and potential
regenerative activity does not change the fact that natural menopause
happens approximately halfway or so through a woman’s chronologi-
cal lifespan. What might change, however, is the thinking behind why
the ovaries fail as a consequence of the aging process. If one draws
parallels to that recently described for males, an intriguing story
emerges that is now worthy of testing in females.
From two separate studies of male mice, it was reported that
whereas age exerts a negative cell-intrinsic impact on the germline,
quiescent spermatogonial stem cells capable of driving spermatogen-
esis do in fact persist in atrophied testes (Ryu et al., 2006; Zhang
et al., 2006). Based on these observations, it has been proposed
that an alteration in the function of somatic cells that support GSC
activity is a key aspect of age-related gonadal failure. Such a conclusion
aligns well with the outcomes of reciprocal transplantation studies in
which atrophied testes of 12-month-old, but not 24-month-old,
males were found to be permissive to a reconstitution of spermato-
genesis by GSC collected from young donor animals (Zhang et al.,
2006). If a similar situation exists in adult females, one could make
the argument that age-related ovarian failure reﬂects impairment in
somatic cell support of GSC activity. The net result would be a loss
of input into the oocyte pool, thus allowing for atresia to rapidly
deplete the remaining follicles in an unabated fashion. Accordingly, it
would be of interest to test if FGSC can be retrieved from aged
ovary tissue and whether such FGSC would retain their ability to
reconstitute oogenesis if transplanted into a young host environment.
In parallel to continued investigations into the regulation and func-
tion of FGSC in mouse ovaries, efforts are needed to determine if a
comparable population of cells exists in human ovaries. Earlier
attempts to provide evidence of mitotic germ cells or meiotic entry
in adult human ovarian tissue were reported as unsuccessful (Liu
et al., 2007), although this work was questioned because of sensitivity
issues with the assays employed to detect low abundance markers of
germ cell renewal (Tilly and Johnson, 2007). Indeed, two subsequent
studies have provided surprising insight into the presence of rare stem-
like cells with germline characteristics in the ovarian surface epithelium
of post-menopausal women. The ﬁrst of these documented the iso-
lation of these cells and their ability to spontaneously form oocytes
or oocyte-like cells in vitro (Virant-Klun et al., 2008a). It was then
reported that oocytes derived from these putative stem cells in vitro
could undergo parthenogenetic activation to form blastocyst-like
structures (Virant-Klun et al., 2008b). Although it remains unknown
if the cells isolated from post-menopausal ovaries represent the
human equivalent of the mouse FGSC identiﬁed by Zou et al.
(2009), these studies nonetheless show that rare germline-like cells
have until now gone undetected in both rodent and human ovaries.
Further, it is noteworthy that the surface epithelial location of the
stem-like cells in post-menopausal ovaries reported by Virant-Klun
et al. (2008a, b) matches initial reports of the location of presumptive
GSC (MVH–BrdU double-positive cells) in juvenile and young adult
mouse ovaries (Johnson et al., 2004). A current challenge will be to
isolate and characterize these cells from human ovaries, which may
prove difﬁcult because of the limited experimental tissue available
for analysis. However, the recent development of a novel culture
system that supports the growth of human ovarian cortical tissue
in vitro (Telfer at al., 2008) may offer a valuable tool to identify putative
GSC in human ovaries for further characterization.
In summary, this new study from Zou et al. (2009) has already gar-
nered a substantial amount of interest from scientists in many disci-
plines (Normile, 2009). Although clearly supportive of and
signiﬁcantly extending earlier work claiming that mammalian GSC
capable of supporting post-natal oogenesis exist, at least in the
mouse (Johnson et al., 2004), there remain many unanswered ques-
tions. A few of these have been highlighted herein, with efforts to
evaluate the physiological signiﬁcance of these FGSC to adult
ovarian function and failure requiring, at least in our view, some pri-
ority. It should also be noted that many stem cell experiments
hailed as major breakthroughs have proven notoriously difﬁcult to
reproduce (reviewed by Check, 2007). Still, the results presented by
Zou et al. (2009) represent an important advance in the ﬁelds of
stem cell and reproductive biology, and several groups will now be
poised to replicate and extend their ﬁndings. Time will tell if the
reported isolation of female GSC from adult mouse ovaries is a repro-
ducible observation, but in the meantime we should be open to its
possibilities. Studies such as these move us a step closer to serious
consideration of how stem cell-based regenerative medicine may
one day become a safe and effective strategy to control the female
biological clock and, as a consequence, the timing of age-related
ovarian failure and menopause when it might be clinically desirable
to do so.
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